The Effect of Salpingectomy Operation on Ovarian Reserve

Evaluation of the Effect of Salpingectomy Operation on Ovarian Reserve With Anti-Mullerian Hormone and Ovarian Doppler Ultrasonography

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06903650

Enrollment

Registered

2025-03-31

Start date

2020-10-27

Completion date

2021-06-05

Last updated

2025-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian Insufficiency

Keywords

Salpingectomy, Ovarian Reserve, Anti-Mullerian Hormone, Doppler Ultrasonography

Brief summary

This study aimed to evaluate the effect of salpingectomy operation on ovarian reserve. Ovarian reserve was evaluated by measuring anti-mullerian hormone levels from serum samples taken from the patients before the operation and 6 weeks after the operation. Ovarian doppler flow were evaluated by measuring the ovarian artery pulsatility index with transvaginal ultrasonography preoperatively, postoperative days 2 and postoperative weeks 6 . In our study, it was determined that ovarian functions may be negatively affected in the acute period after salpingectomy operation.

Interventions

PROCEDUREbilateral salpingectomy, ovarian arter doppler ultrasonography

The effect of salpingectomy operation on ovarian reserve

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

37 Years to 45 Years

Healthy volunteers

Yes

Inclusion criteria

1. Women between the ages of 37-45 with continuing menstrual cycles (37 and 45 included) 2. Patients who will undergo uterine surgery for benign reasons or who will undergo salpingectomy only due to hydrosalpinx, ectopic pregnancy, tubo-ovarian abscess 3. Patients who have not had ovarian surgery before 4. Those without menopause and premature ovarian failure 5. Patients who accept the study

Exclusion criteria

1. Age younger than 37 or older than 45 2. Those who want to withdraw from the study 3. Those who do not come for follow-up examination 4. Use of drugs that affect ovarian reserve 5. Any surgical procedure performed on the ovaries during the operation 6. No menstrual bleeding in the last year 7. Patients who received radiotherapy and hormonal therapy within 3 months before surgery

Design outcomes

Primary

Measure	Time frame	Description
right ovarian arter pı	perioperative, postoperative days 2 , postoperative weeks 6	rate of 0,87/ 0,84/ 0,76
left ovarian arter pı	perioperative, postoperative days 2, postoperative weeks 6	rate of 0,89/ 0,79/ 0.80
AMH levels	perioperative-postoperative weeks 6	Concentration of 1 ng/mL / 0,79 ng/mL

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026